Some patients may use medication for a shorter period, while others may require longer-term treatment and monitoring
Cystinosin deficiency leads to impaired lysosomal clearance and disrupted endolysosomal trafficking, which in turn contributes to defective autophagy and altered proteostasis [144, 146, 147]
March 2025 : Celltrion launched STEQEYMA (ustekinumab-stba), a biosimilar to STELARA for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA), Crohn's disease (CD), and ulcerative colitis
GLP-1 Receptor Agonists (review)
It is about who controls the information patients receive, which evidence gets highlighted, and what gets left in the fine print
Increased IGF-1 levels: Co-administration promotes higher systemic IGF-1, improving muscle protein synthesis, recovery, and lipolysis